Unlike loss-of-function, as occurs in profilin KO cells, pathogenic INF2 mutations cause FSGS through a gain-of-function mechanism, consistent with the Mendelian-dominant inheritance of INF2-linked disease. Here, INF2 is linked to focal segmental glomerulosclerosis.